You are here:
A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.
Together with the Weizmann Institute of Science, Garvan has officially opened the Garvan-Weizmann Centre for Cellular Genomics, the first of its kind in Australia.
Garvan has now sequenced more than 15,000 whole genomes, a major milestone for the Kinghorn Centre for Clinical Genomics (KCCG) and Garvan’s wholly owned subsidiary, Genome.One.